Repurposing glucocorticoids as adjuvant reagents for immune checkpoint inhibitors in solid cancers

被引：4
|
作者：
Yu, Yingyan [1 ]
机构：
[1] Shanghai Jiao Tong Univ, Ruijin Hosp, Shanghai Inst Digest Surg, Dept Gen Surg,Sch Med,Shanghai Key Lab Gastr Neop, Shanghai 200025, Peoples R China
来源：
CANCER BIOLOGY & MEDICINE | 2021年 / 18卷 / 04期
基金：
中国国家自然科学基金;
关键词：
RESISTANCE; SURVIVAL; COVID-19; GENES;
D O I：
10.20892/j.issn.2095-3941.2021.0491
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：944 / 948
页数：5
相关论文
共 50 条
  • [41] Safety of COVID-19 vaccines in subjects with solid tumor cancers receiving immune checkpoint inhibitors
    Gilbert, Danielle
    Hu, Junxiao
    Medina, Theresa
    Kessler, Elizabeth R.
    Lam, Elaine T.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2023, 19 (01)
  • [42] Immune Checkpoint Inhibitors for Solid Tumors in the Adjuvant Setting: Current Progress, Future Directions, and Role in Transplant Oncology
    Abboud, Karen
    Umoru, Godsfavour
    Esmail, Abdullah
    Abudayyeh, Ala
    Murakami, Naoka
    Al-Shamsi, Humaid O. O.
    Javle, Milind
    Saharia, Ashish
    Connor, Ashton A. A.
    Kodali, Sudha
    Ghobrial, Rafik M. M.
    Abdelrahim, Maen
    CANCERS, 2023, 15 (05)
  • [43] Sensitizing immune unresponsive colorectal cancers to immune checkpoint inhibitors through MAVS overexpression
    Hwang, Bin-Jin
    Tsao, Li-Chung
    Acharya, Chaitanya
    Trotter, Timothy
    Agarwal, Pankaj
    Wang, Tao
    Wei, Junping
    Yang, Xiao-Yi
    Lei, Gang-Jun
    Osada, Takuya
    Lyerly, Herbert Kim
    Morse, Michael A.
    Hartman, Zachary
    CANCER RESEARCH, 2022, 82 (12)
  • [44] Resistance to immune checkpoint inhibitors in advanced gastro-oesophageal cancers
    Mark A. Baxter
    Fearghas Middleton
    Hannah P. Cagney
    Russell D. Petty
    British Journal of Cancer, 2021, 125 : 1068 - 1079
  • [45] Research Progress of Biomarkers for Immune Checkpoint Inhibitors on Digestive System Cancers
    Wang, Jingting
    Ma, Xiao
    Ma, Zhongjun
    Ma, Yan
    Wang, Jing
    Cao, Bangwei
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [46] Sensitizing immune unresponsive colorectal cancers to immune checkpoint inhibitors through MAVS overexpression
    Hwang, Bin-Jin
    Tsao, Li-Chung
    Acharya, Chaitanya R.
    Trotter, Timothy
    Agarwal, Pankaj
    Wei, Junping
    Wang, Tao
    Yang, Xiao-Yi
    Lei, Gangjun
    Osada, Takuya
    Lyerly, Herbert Kim
    Morse, Michael A.
    Hartman, Zachary Conrad
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (03)
  • [47] Vaccines and immune checkpoint inhibitors: a promising combination strategy in gastrointestinal cancers
    Bashir, Babar
    Flickinger, John C.
    Snook, Adam E.
    IMMUNOTHERAPY, 2021, 13 (07) : 561 - 564
  • [48] Resistance to immune checkpoint inhibitors in advanced gastro-oesophageal cancers
    Baxter, Mark A.
    Middleton, Fearghas
    Cagney, Hannah P.
    Petty, Russell D.
    BRITISH JOURNAL OF CANCER, 2021, 125 (08) : 1068 - 1079
  • [49] Efficacy and toxicity of immunotherapy with immune checkpoint inhibitors in gynecologic cancers.
    Kuznicki, Michelle
    Joehlin-Price, Amy
    Rose, Peter Graham
    Mahdi, Haider
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [50] DNA Mismatch Repair Deficiency and Immune Checkpoint Inhibitors in Gastrointestinal Cancers
    Ruiz-Banobre, Juan
    Goel, Ajay
    GASTROENTEROLOGY, 2019, 156 (04) : 890 - 903
12345